Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( May )
Should I stay or should I go?
There are no easy answers when it comes to timing a job move, says Tim Ewbank, but you can make yourself a more attractive candidate for that next job.(more)
Regional research still hampered by cross-border differences
In the age of the Euro-trial, patients are not well served by processes that add unnecessary delays to the development of new medicines, says Les Rose(more)
A sea of paperwork or business as usual?
Steven Gray looks ahead to the soon-to-be finalised 2008 ABPI Code of Practice and how it will affect everyday practice in the UK industry(more)
PharmafocusNews Register for New Alert
News for December 2005
Previous Months: April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

FDA approves Bayer's kidney cancer drug
Nexavar poised for European approval in 2006..(more)

 Tamiflu-resistant bird flu found
DH looks at Relenza as back-up to Tamiflu..(more)

 Politics and Healthcare - still a volatile mix
Herceptin access controversy a big issue for pharma in 2005..(more)

 Bird flu tops 2005 global health concerns
WHO survey identifies top 10 health issues for 2005..(more)

 Woman wins right to Herceptin trial
Swindon PCT refuses access to Herceptin..(more)

 Pfizer lifted by Lipitor patent victory
Pfizer defeats Ranbaxy in US trial..(more)

 Prexige wins approval in UK
Safety review of Cox-II class delays drug's launch..(more)

 Private sector vital for Government plans for patient choice
Private sector vital to driving waiting lists down..(more)

 Seven Stones wins General Electric Healthcare account
Specialist healthcare agency prevails in competitive pitch..(more)

 US regulator looks to improve communication strategy
FDA aims to improve drug safety communications..(more)

 Merck disappointed after jury undecided in Vioxx case
Mistrial casts doubt on Merck's case..(more)

 AstraZeneca doubles trial size for stroke drug
AstraZeneca seeks to avoid same fate as Exanta..(more)

 Brooksby to be new ABPI president
Sanofi-Aventis UK managing director to take over in April..(more)

 McKillop calls for changes to EU pharmaceutical market
Action is needed on pricing and clinical trials environment ..(more)

 J&J submits new schizophrenia drug
J&J submits Paliperidone ER to FDA..(more)

 Shire and New River expect new ADHD launch in 2006
New River files new treatment with FDA..(more)

 £350 million needed for stem cell research
Government to pump extra £50 million into stem cell research..(more)

 Research plans attract £1 billion investment from industry
Curbing animal rights extermism crucial to success..(more)

 UK biotech signs $230 million deal with Genentech
PIramed focused on drug discovery in oncology ..(more)

 Merck seeks US approval for cancer vaccine
Merck's Gardasil to face competition from GSK's Cervarix..(more)

 Pharmacies offer lab tests for long-term conditions
6,000 patients could benefit from new pilot project..(more)

 CIPR to debate impact of new prescribers
Prescribing powers for nurses and pharmacists on agenda..(more)

 Rx Award wins for Paling Walters and LEC Advertising
Paling Walters wins Gold for Roche campaign..(more)

 58,000 people living with HIV in the UK
Report shows rates of infection vary across the country..(more)

 Merck plans diabetes compliance campaign
Medicom hired to improve Glucophage SR compliance..(more)

 Sanofi-Aventis throws its weight behind Acomplia
Sanofi-Aventis gearing up for the launch of Acomplia..(more)

 New UK headquarters for Bristol-Myers Squibb
Offices to symbolise commitment to investing in UK..(more)

 Scheuble quits as Merck KGaA chief
Failure to build strong presence in US source of friction..(more)

 Pfizer's new anti-smoking drug shows promise
Drug to be marketed under brand name Champix, if approved..(more)

 Pfizer critical of generic plan for three million statin patients
NICE advises prescribing generic simvastatin..(more)

 Altana and Serono seeking mergers
Pfizer and Novartis among those tipped as suitors..(more)

 GlaxoSmithKline's lapatinib hailed as latest 'wonder drug'
New oral once-daily treatment to be marketed as Tykerb..(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2006 Pharmafile Ltd.